- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Wilson disease
- Meeting Date: November 2021
- Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 1199KB)
- Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 351KB)
Trientine – November 2021
Trientine: Capsule containing trientine dihydrochloride 250 mg (equivalent to 166.7 mg trientine); Waymade®
Last updated
11 October 2022